Find a Clinical Trial

Showing 1 - 7 out of 7

R3R

A Phase II, Multi-center, Open-Label Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of R3R01 in Alport Syndrome Patients with Uncontrolled Proteinuria on ACE/ARB Inhibition and in Patients with Primary Steroid-Resistant Focal Segmental Glomerulosclerosis

Chronic kidney disease

All genders

12+

Recruiting now

Department of Medicine, Division of Nephrology

Tufts Medical Center

Learn more

VX19-NEN-801

A Study of the Prevalence of Apolipoprotein L1 (APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin

Chronic kidney disease, Glomerular disease, Kidney diseases, Proteinuria

All genders

12-65

Recruiting now

Department of Medicine, Division of Nephrology

Tufts Medical Center

Learn more

NRAD

Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress, and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Disease.

Alzheimer's disease, Mild cognitive impairment

All genders

55-89

Recruiting now

Department of Psychiatry

Tufts Medical Center

Learn more

ROACTIVE-HF II

Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor
System in New York Heart Association (NYHA) Class II-III Heart Failure Patients
(PROACTIVE-HF-2 Trial)

Heart failure

All genders

18+

Recruiting now

Division of Cardiology

Tufts Medical Center

Learn more

OCS Heart Perfusion Registry

OCS Heart Perfusion Post- Approval Registry

Heart transplantation

All genders

18+

Recruiting now

CardioVascular Center

Tufts Medical Center

Learn more

THC-AD

Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer’s disease (AD) (THC-AD)

Alzheimer's disease, Psychiatric disorders

All genders

60-95

Recruiting now

Department of Psychiatry

Tufts Medical Center

Learn more

Pulmonary vascular impedance in cardiogenic shock

Pulmonary vascular impedance as a novel tool to understand right ventricular afterload in cardiogenic shock

Heart failure, Shock

All genders

18+

Recruiting now

CardioVascular Center

Tufts Medical Center

Learn more

Find Care

Services + Treatments

Patients + Visitors

Research + Academics

Clinicians

Find a Clinical Trial

Filter

A Phase II, Multi-center, Open-Label Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of R3R01 in Alport Syndrome Patients with Uncontrolled Proteinuria on ACE/ARB Inhibition and in Patients with Primary Steroid-Resistant Focal Segmental Glomerulosclerosis

A Study of the Prevalence of Apolipoprotein L1 (APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin

Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress, and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Disease.

Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor
System in New York Heart Association (NYHA) Class II-III Heart Failure Patients
(PROACTIVE-HF-2 Trial)

OCS Heart Perfusion Post- Approval Registry

Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer’s disease (AD) (THC-AD)

Pulmonary vascular impedance as a novel tool to understand right ventricular afterload in cardiogenic shock

Find Care

Services + Treatments

Patients + Visitors

Research + Academics

Clinicians

Find a Clinical Trial

Filter

A Phase II, Multi-center, Open-Label Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of R3R01 in Alport Syndrome Patients with Uncontrolled Proteinuria on ACE/ARB Inhibition and in Patients with Primary Steroid-Resistant Focal Segmental Glomerulosclerosis

A Study of the Prevalence of Apolipoprotein L1 (APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin

Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress, and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Disease.

Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial)

OCS Heart Perfusion Post- Approval Registry

Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer’s disease (AD) (THC-AD)

Pulmonary vascular impedance as a novel tool to understand right ventricular afterload in cardiogenic shock

Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor
System in New York Heart Association (NYHA) Class II-III Heart Failure Patients
(PROACTIVE-HF-2 Trial)